Market Closed

ATYR
aTyr Pharma
$ 6.11
-1.61%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago

aTyr Pharma News

Latest aTyr Pharma Stock News & ATYR Headlines

aTyr Pharma to Participate in Upcoming Investor Conferences
4 days ago | globenewswire.com
aTyr Pharma Announces Publication of Results from the Phase 3 EFZO-FIT™ Study of Efzofitimod in Pulmonary Sarcoidosis in The Lancet Respiratory Medicine
17 days ago | globenewswire.com
aTyr Pharma Announces One-for-40 Reverse Stock Split
19 days ago | globenewswire.com
aTyr Pharma Announces Research Collaboration with Montefiore Einstein
a month ago | globenewswire.com
aTyr Pharma Announces Publication Demonstrating Anti-Fibrotic Effects of ATYR0101 in the Journal of Biological Chemistry
a month ago | globenewswire.com
Positive FDA Alignment Boosts ATyr Pharma's Rare Lung Disease
2 months ago | benzinga.com
aTyr Pharma Announces Alignment with FDA on Phase 3 Study of Efzofitimod in Pulmonary Sarcoidosis
2 months ago | globenewswire.com
aTyr Pharma Provides Update on Timing of Regulatory Response for Planned Phase 3 Study of Efzofitimod in Pulmonary Sarcoidosis
2 months ago | globenewswire.com
aTyr Pharma Announces Second Quarter 2026 Results, Program Prioritization and Corporate Restructuring to Support Efzofitimod Program in ILD
3 months ago | globenewswire.com
aTyr Pharma to Present Subgroup Analysis of Phase 3 EFZO-FIT™ Study of Efzofitimod in Pulmonary Sarcoidosis at WASOG 2026
4 months ago | globenewswire.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

ATYR
aTyr Pharma
$ 6.11
-1.61%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago